Logo image of LBGJ

LI BANG INTERNATIONAL CORP I (LBGJ) Stock Fundamental Analysis

NASDAQ:LBGJ - Nasdaq - KYG5480M1024 - Common Stock - Currency: USD

1.24  +0.06 (+5.2%)

Fundamental Rating

1

Taking everything into account, LBGJ scores 1 out of 10 in our fundamental rating. LBGJ was compared to 127 industry peers in the Machinery industry. LBGJ has a bad profitability rating. Also its financial health evaluation is rather negative. LBGJ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LBGJ had negative earnings in the past year.
LBGJ had a negative operating cash flow in the past year.
LBGJ Yearly Net Income VS EBIT VS OCF VS FCFLBGJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M 2M 3M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.67%, LBGJ is doing worse than 78.74% of the companies in the same industry.
LBGJ has a worse Return On Equity (-32.19%) than 82.68% of its industry peers.
Industry RankSector Rank
ROA -8.67%
ROE -32.19%
ROIC N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)-1.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LBGJ Yearly ROA, ROE, ROICLBGJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

Looking at the Gross Margin, with a value of 22.88%, LBGJ is doing worse than 68.50% of the companies in the same industry.
LBGJ's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LBGJ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.42%
GM growth 5YN/A
LBGJ Yearly Profit, Operating, Gross MarginsLBGJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

LBGJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LBGJ has less shares outstanding
Compared to 1 year ago, LBGJ has a worse debt to assets ratio.
LBGJ Yearly Shares OutstandingLBGJ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
LBGJ Yearly Total Debt VS Total AssetsLBGJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 1.32, we must say that LBGJ is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.32, LBGJ is doing worse than 77.95% of the companies in the same industry.
A Debt/Equity ratio of 1.36 is on the high side and indicates that LBGJ has dependencies on debt financing.
LBGJ has a Debt to Equity ratio of 1.36. This is amonst the worse of the industry: LBGJ underperforms 82.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACCN/A
WACC7.8%
LBGJ Yearly LT Debt VS Equity VS FCFLBGJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

A Current Ratio of 1.85 indicates that LBGJ should not have too much problems paying its short term obligations.
LBGJ has a Current ratio (1.85) which is comparable to the rest of the industry.
LBGJ has a Quick Ratio of 1.70. This is a normal value and indicates that LBGJ is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.70, LBGJ is doing good in the industry, outperforming 70.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.7
LBGJ Yearly Current Assets VS Current LiabilitesLBGJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

LBGJ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -216.89%.
The Revenue for LBGJ has decreased by -12.54% in the past year. This is quite bad
Measured over the past years, LBGJ shows a very negative growth in Revenue. The Revenue has been decreasing by -12.12% on average per year.
EPS 1Y (TTM)-216.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.14%
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-12.12%
Revenue growth 5YN/A
Sales Q2Q%26.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LBGJ Yearly Revenue VS EstimatesLBGJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LBGJ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LBGJ Price Earnings VS Forward Price EarningsLBGJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LBGJ Per share dataLBGJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LBGJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LI BANG INTERNATIONAL CORP I

NASDAQ:LBGJ (8/8/2025, 8:00:02 PM)

1.24

+0.06 (+5.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.25M
AnalystsN/A
Price TargetN/A
Short Float %0.19%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.5
P/FCF N/A
P/OCF N/A
P/B 3
P/tB 3.22
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.83
BVpS0.41
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.67%
ROE -32.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.88%
FCFM N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)-1.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.42%
GM growth 5YN/A
F-Score2
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.5%
Cap/Sales 0.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.7
Altman-Z 1.32
F-Score2
WACC7.8%
ROIC/WACCN/A
Cap/Depr(3y)24.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.95%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-216.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.54%
Revenue growth 3Y-12.12%
Revenue growth 5YN/A
Sales Q2Q%26.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-775.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y7.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.91%
OCF growth 3YN/A
OCF growth 5YN/A